Bradycardia Induced by Hyperkalemia M r. D, a 57 year old White man, walked into the health clinic at work during the afternoon complaining of "not feeling right." He stated that hefelt a little short ofbreath the day before and in the morning, but that was not atypical given his history of asthma. He experienced dizziness upon rising, which had progressed to feeling off balance, especially with activity. He described a near syncopal event while getting out of the car at lunch.
The occupational health nurse checked his vital signs: blood pressure 100160, heart rate 48, and respiratory rate 20. Physical examination revealed diminished breath sounds bilaterally and regular; but faint SjS2 with a functioning prosthetic valve and systolic ejection murmur. Mr. D was alarmed. His blood pressure and heart rate had never been that low. Mr. D had an extensive cardiac history and was seeing a cardiologist every 6 months. His condition had been stable since his bypass surgery and mitral valve replacement 2 years prior. He reported that the cardiologist had not changed any medications. Mr. D's daily drug therapy included digoxin (Lanoxin) .125 mg, 
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CLINICAL PRESENTATION
Persistent dizziness or a near syncopal event commonly causes clients to seek medical attention (Hammill, 1997) . Often, noninvasive assessment can help to diagnose the problem. A change in both blood pressure and heart rate might indicate a cardiac cause for the syncope.
The occupational health nurse recognized that syncope was related to the bradycardia that in turn was possibly caused by the hyperkalemia. Although Mr. D was able to function despite the low heart rate, the dysrhythmia or relative symptomatic bradycardia he was experiencing required immediate intervention.
Defining Characteristics ofBradycardia
Symptomaticbradycardiadescribes both a heart rhythm disturbance and the response to the disturbance. The term is used to describe a slow heart rate coupled with hemodynamic compromise. "Symptomatic" implies that the client is experiencing any of myriad complaints, such as hypotension, orthostatic changes, diaphoresis, angina, dizziness, shortness of breath, weakness, fatigue, or "spells." If the client can still function, the rhythm is termed relative symptomatic bradycardia. If the client is near cardiovascular collapse, the rhythm is called absolute symptomatic bradycardia.
Electrolytes and Dysrhythmias
Cardiac electrical activity results from movement of electrolytes across the cell membrane. Abnormalities in electrolyte concentrations affect the conduction system of the heart and subsequently influence the EKG. When evaluating the EKG for underlying pathology, nurses should ascertain that calcium, magnesium, and potassium are at normal levels. Potassium derangements are of particular importance.
EKG Changes Associated with Hyperkalemia
While less common than hypokalemia, hyperkalemia is often more dangerous and is associated with potentially lethal dysrhythmias such as ventricular tachycardia and ventricular fibrillation. Additional rhythm changes related to hyperkalemia are sinus bradycardia, sinus arrest, and slow idioventricular rhythms. Typical EKG changes include peaked T waves, flattened or absent P waves, and widened QRS complex (Greenberg, 1998) . It is important to remember that specific EKG changes are not directly correlated to varying levels of hyperkalemia (Chmielewski, 1998; Greenberg, 1998) . In some cases of hyperkalemia, EKG changes are not seen (Greenberg, 1998) .
TREATMENT
Symptomatic bradycardia requires hospitalization for further monitoring. The pivotal clinical issue is whether the reported symptoms are caused by bradycardia or by some other pathology causing the bradycardia. Often, the EKG may be nondiagnostic (Hammill, 1997) . Bloodwork and medication history may provide important clues related to the cause for the dizziness. Serum chemistries indicate whether or not electrolytes and renal insufficiency are influencing pathology. Medications that may adversely slow conduction through the AV node should be stopped (e.g., beta-blockers, calcium channel blockers, digoxin, amiodarone).
In Mr. D's case, the immediate concern was to correct the potassium level, thereby increasing the heart rate and, ideally, abating symptoms. If symptoms persisted afterelectrolytes were normalized and any possible offending medications were stopped, then further work-up would be required.
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IDENTIFYING HIGH RISK POPULATIONS
The leading cause of hyperkalemia is supplemental potassium. A review of Mr. D's medications showed that although he was not on a potassium supplement, he was still at risk for hyperkalemia. The combination of an angiotensin-converting enzyme (ACE) inhibitor and a potassium-sparing diuretic put him at risk for hyperkalemia, especially in the presence of renal insufficiency. This common drug combination is the current recommended treatment for patients who have myocardial ischemia and have systolic dysfunction (Jessup, 2003 
SUMMARY
The incidence of chronic cardiac disease is increasing (Jessup, 2003) . As a result, it is important for occupational health nurses to recognize adverse effects (e.g., electrolyte abnormalities, dysrhythmias) associated with current treatment guidelines (Hunt, 200 I) . As shown in the example in this case study, the Current rec-ommended treatment for clients who have myocardial ischemia and left ventricular dysfunction (i.e., ACE inhibitor and a potassium-sparing diuretic) puts clients at risk for hyperkalemia, especially in the presence of renal insufficiency.
